In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors
- 669 Downloads
The need for novel therapeutics against Plasmodium falciparum is urgent due to recent emergence of multi-drug resistant malaria parasites. Since fatty acids are essential for both the liver and blood stages of the malarial parasite, targeting fatty acid biosynthesis is a promising strategy for combatting P. falciparum. We present a combined computational and experimental study to identify novel inhibitors of enoyl-acyl carrier protein reductase (PfENR) in the fatty acid biosynthesis pathway. A small-molecule database from ChemBridge was docked into three distinct PfENR crystal structures that provide multiple receptor conformations. Two different docking algorithms were used to generate a consensus score in order to rank possible small molecule hits. Our studies led to the identification of five low-micromolar pyrimidine dione inhibitors of PfENR.
KeywordsComputer-aided drug discovery Enoyl-acyl carrier protein reductase Virtual screening
We would like to thank Dr. Jacob Durrant for helpful discussions and careful reading of the manuscript. Additionally we would like to thank Dr. Victoria Feher for her help with ordering the ChemBridge compounds. This work was supported by the National Institutes of Health NIH R21A090213, NIH R01GM094924, and NIH R01GM095970 (MDB), and the National Science Foundation, the National Institutes of Health, the Howard Hughes Medical Institute, the National Biomedical Computation Resource, and the NSF Supercomputer Centers (JAM). Computational resources were supported, in part, by the National Science Foundation grant PHY-0822283, the Center for Theoretical Biological Physics. S. L. was supported by the American Heart Association (12POST11570005) and the Center for Theoretical Biological Physics. L.T. was supported by the San Diego Match Fellowship and the University of California Interfaces Training Grant. We would like to acknowledge the UCSD Chemistry and Biochemistry Mass Spectrometry Facility; Professor Pieter Dorrestein and Dr. Jane Yang for providing the P. falciparum ENR plasmid; Dr. James La Clair, Dr. Joris Beld, and Christopher Vickery for manuscript design and input; and Dr. Nicolas Kosa for enzymatic assay and protein expression consulting.
- 20.Jackowski S, Murphy CM, Cronan JE Jr, Rock CO (1989) Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. J Biol Chem 264:7624–7629Google Scholar
- 21.Nishida I, Kawaguchi A, Yamada M (1986) Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli. J Biochem 99:1447–1454Google Scholar
- 26.McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW (2001) Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol 31:109–113CrossRefGoogle Scholar
- 27.Tallorin L, Durrant JD, Nguyen QG, McCammon JA, Burkart MD (2014) Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase. Biorgan Med Chem. doi: 10.1016/j.bmc.2014.09.002
- 31.Belluti F, Perozzo R, Lauciello L, Colizzi F, Kostrewa D, Bisi A, Gobbi S, Rampa A, Bolognesi ML, Recanatini M, Brun R, Scapozza L, Cavalli A (2013) Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI). J Med Chem 56:7516–7526CrossRefGoogle Scholar
- 33.Maity K, Bhargav SP, Sankaran B, Surolia N, Surolia A, Suguna K (2010) X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. IUBMB Life 62:467–476Google Scholar
- 49.Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749CrossRefGoogle Scholar
- 53.Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461Google Scholar
- 55.Lindert S, Zhu W, Liu YL, Pang R, Oldfield E, McCammon JA (2013) Farnesyl diphosphate synthase inhibitors from in silico screening. Chem Biol Drug Des 81(6):742–748Google Scholar
- 59.Choi KH, Kremer L, Besra GS, Rock CO (2000) Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem 275:28201–28207Google Scholar